作者: Elisabeth Mahase
DOI: 10.1136/BMJ.M4564
关键词:
摘要: The covid-19 vaccine candidate developed by the University of Oxford is 90% effective when a person initially given half dose followed full dose, interim phase III trial results show. The analysis included 131 cases and showed was 62% as two standard doses (8895 participants) one month apart, but regime (2741) used. No hospitalised or severe were found in anyone who received vaccine. The findings have not yet been peer reviewed published, press released on 23 November. team said they hoped to submit for publication within 24 hours. The vaccine’s manufacturer, AstraZeneca, that four million will …